Medtronic expanding imaging in India; Hospira strikes deal to get pumps back on U.S. market;

 @FierceMedDev: J&J device revenue jumped 6.4% in 2012 thanks to Synthes buy. Report | Follow @FierceMedDev

 @DamianFierce: If $LIFE is indeed for sale, that's not stopping it from pursuing more M&A of its own. More | Follow @DamianFierce

> Medtronic ($MDT) is working to expand its O-Arm Intra-operative 3-D surgical imaging device in India, in keeping with CEO Omar Ishrak's goal of boosting the company's presence in emerging markets. Article

> SafeStitch Medical got some positive results for its GERD- and obesity-treating device, and the company is planning to submit an IDE this year and pursue full FDA approval. More

> Hospira ($HSP) has entered into a deal with Q Core Medical, giving the company exclusive rights to market and distribute Q Core's Sapphire infusion pump. The agreement opens up a revenue stream for Hospira after the FDA blocked the importation of its Symbiq pumps back in November. News | Background

> Moog Medical Devices is expanding its recall of administration sets to include another production lot. Item

> Mallinckrodt, Covidien's ($COV) soon-to-be-spun-out drug business, got FDA approval for a prefilled-syringe variety of Gablofen, a treatment for spinal spasticity. Release

> Teleflex ($TFX) snagged FDA clearance for its Arrow UltraQuik peripheral nerve block needles. Report

> Israel's Brainsway ($BRIN) expects to find a commercialization partner this quarter for its recently FDA-approved device to treat depression. Story

Biotech News

 @FierceBiotech: Novo Nordisk nabs European OK on blockbuster diabetes drug hopeful. News | Follow @FierceBiotech

@JohnCFierce: As CRL letters go, Impax would seem to have a low hurdle ahead on its sustained release Parkinson's drug. More | Follow @JohnCFierce

@RyanMFierce: Software outfit tackles multi-billion dollar bugaboo in clinical trials. Article | Follow @RyanMFierce

> New $80M venture fund to back startups entering 'valley of death.' Story

> Biotech vet Astley-Sparke takes U.S. lead for pioneering gene therapy player. Article

Pharma News

@FiercePharma: ADHD diagnoses up 24% over past 10 years; study author cites "better diagnosis" and possible "upward trend." More | Follow @FiercePharma

 @AlisonBFierce: Vanderbilt University has emerged as a leading institution for central nervous system drug research and discovery. Editor's Corner | Follow @AlisonBFierce

@EricPFierce: Plant problems stymie Impax NDA for Parkinson drug, FDA says. Article | Follow @EricPFierce

> Amgen's Sensipar scored pricing shield from Congress. News

> Novo ready to rev up Tresiba for European launch. Report

Biotech IT News

> New chief named for Perceptive Informatics. Story

> U.K. regulator finds social media groove…finally. Item

> Software outfit tackles multi-billion dollar bugaboo in clinical trials. Article

> Elsevier rumored as potential buyer of open science startup. News

CRO News

> Is GlaxoSmithKline stretching its contractors too thin? Story

> Covance teams with U.K.'s NHS Trust on Phase I trials. Report

> Clinipace rejiggers eClinical platform. Article

> Quintiles lands pathology accreditation for Indian lab. News

Pharma Manufacturing News

> BASF lands Pronova making it a top omega-3 maker. Report

> Pfizer to develop laser cleaning verification system. Item

> Cargo theft down in year of key arrests. News

> Plant problems stymie Impax NDA, FDA says. Article

Biotech Research News

> Calcium receptor could stop sleeping sickness in its tracks. Item

> Oral breast cancer vaccine could prevent recurrence. Article

> A great leap forward: Microdystrophin gene therapy success in dogs. Report

> Glowing mice could blaze way for detecting, tracking cancer growth. News

Sponsored By Paraza Pharma

Choosing the Right Pre-Clinical Collaborative Research Organization (CRO)

Learn about the key factors that are essential to creating a collaborative and productive working relationship to advance pre-clinical drug discovery programs.